TWOEquity · Weekly research terminal

4147

TaiMed Biologics Inc.

TW Healthcare Biotechnology

Latest week
14 Aug 2026
Weekly close
64.20 TWD
Fair value
78.67 TWD
Next-week expectancy
Negative 43.50%
Crowd view
Current verdict No votes yet Be first to vote

Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TWO · Equity · Taiwan

4147

TaiMed Biologics Inc.

Healthcare Biotechnology

TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases. The company develops and markets Trogarzo IV infusion and Trogarzo IV push, a monoclonal antibody for HIV treatment. It is also developing TMB-365, a monoclonal antibody used for HIV treatment and prevention which has completed a phase-1 clinical trial; and TMB-365 and TMB-380 combination, a monoclonal antibody combination therapy for HIV that is …

Last updated
14 Aug 2026
Exchange
Taipei Exchange · TWO
Sector
Healthcare
Industry
Biotechnology
Currency
TWD
Market capitalisation
17,379,094,528
Fair value reference
78.67
Next-week expectancy
Negative · 43.50%

Over the latest 12 completed weeks ending 2026-08-14, 4147 rose 30.36%, moving from 49.25 to 64.20. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 4 of the last 12 weeks. Relative Strength is -28.58 and has improved across the 12-week window. Market Dynamics is 0.62 on the latest week. Next-week expectancy is negative at 43.50% based on similar historical setup states.

Week Ending
14 Aug 2026
Latest Close
64.20
12-Week Change
30.36%
Trend Signal
Active
Next-Week Expectancy
Negative 43.50%
Signal Weeks
4 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
14 Aug 2026
Latest Close
64.20
12-Week Change
30.36%
Trend Signal
Active
Next-Week Expectancy
Negative 43.50%
Signal Weeks
4 of 12
Vs Trend Line
Above
Vs Fair Value
Below
Relative Strength
-28.58
Market Dynamics
0.62

Over the latest 12 completed weeks ending 2026-08-14, 4147 rose 30.36%, moving from 49.25 to 64.20. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 4 of the last 12 weeks. Relative Strength is -28.58 and has improved across the 12-week window. Market Dynamics is 0.62 on the latest week. Next-week expectancy is negative at 43.50% based on similar historical setup states.

Industry Peers

Taiwan equities in Biotechnology

Stock Exchange Week Open High Low Close Change
6696 Lin BioScience, Inc. TWO 14 Aug 2026 708.00 930.00 684.00 912.00 28.81%
7832 Intelligene TWO 14 Aug 2026 11.75 13.55 11.75 13.55 15.32%
6949 Pell Bio-Med Technology Co., Ltd. TAI 14 Aug 2026 943.00 1090.00 914.00 1070.00 13.47%
6848 RBC Bioscience Corporation TWO 14 Aug 2026 19.05 23.45 19.05 21.55 13.12%
6810 Bio Preventive Medicine Corp. TWO 14 Aug 2026 21.05 24.15 20.70 23.05 9.50%
7776 Anya TWO 14 Aug 2026 30.00 33.15 29.85 32.50 8.33%
6945 AP Biosciences, Inc. TWO 14 Aug 2026 99.00 116.50 99.00 104.50 5.56%
6492 Senhwa Biosciences, Inc. TWO 14 Aug 2026 37.50 39.65 36.90 38.80 3.47%
4732 NatureWise Biotech & Medicals Corporation TWO 14 Aug 2026 15.95 16.70 15.90 16.50 3.45%
7827 HanchorBio Inc. TAI 14 Aug 2026 156.00 164.50 153.50 161.00 3.21%
7773 FullHope TWO 14 Aug 2026 26.30 27.10 25.90 27.10 3.04%
4911 G&E Herbal Biotechnology Co., Ltd. TWO 14 Aug 2026 28.00 28.95 28.00 28.85 3.04%
7837 Creative TWO 14 Aug 2026 70.00 72.10 70.00 72.10 3.00%
7725 LabTurbo Biotech Corporation TWO 14 Aug 2026 21.70 22.30 21.70 22.30 2.76%
6589 EirGenix Inc. TAI 14 Aug 2026 50.20 52.90 50.00 51.50 2.59%
4743 Oneness Biotech Co., Ltd. TWO 14 Aug 2026 45.60 48.70 45.10 46.50 1.97%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context